SPAG16-DT: A Drug Target / Disease Biomarker (G100130451)

Target Name: SPAG16-DT

NCBI ID: G100130451

SPAG16-DT

Other Name(s): SPAG16 divergent transcript | SPAG16 divergent transcript, transcript variant 2

SPAG16-DT: A Drug Target / Disease Biomarker

SPAG16-DT is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key component of the spatial organization of microtubules in these cells, and is involved in the regulation of cell division, differentiation, and transport of organelles within the cell.

SPAG16-DT has been identified as a potential drug target in the field of neurodegenerative diseases, due to its involvement in the regulation of neuronal structure and function. It has been shown to play a role in the development and progression of conditions such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, by contributing to the misfolding and misregulation of neuronal proteins.

In addition to its role in neurodegenerative diseases, SPAG16-DT has also been shown to be involved in the regulation of various physiological processes in the body, including cell growth, migration, and the response to stimuli. It has been shown to play a role in the regulation of the blood-brain barrier, which is responsible for controlling the movement of substances into and out of the brain, and is thought to be a potential drug target for various neurological conditions.

SPAG16-DT is a protein that is expressed in a wide range of tissues and cells of the body, and its function and regulation are still being fully understood. However, its potential as a drug target is significant, as it has been shown to be involved in the regulation of a wide range of physiological processes, and its dysfunction has been implicated in a variety of neurodegenerative diseases.

In conclusion, SPAG16-DT is a protein that has been identified as a potential drug target in the field of neurodegenerative diseases. Its role in the regulation of microtubule structure and function, as well as its involvement in the regulation of various physiological processes, make it an attractive target for drug development. Further research is needed to fully understand its function and regulation, and to determine its potential as a drug.

Protein Name: SPAG16 Divergent Transcript

The "SPAG16-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPAG16-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets